SCHEMBL25873391

SCHEMBL25873391

Cc1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 8/20 0.85
MEN1 O00255 1/20 0.85
NR1I2 O75469 1/20 0.85
USP2 O75604 1/20 0.85
ABCB11 O95342 1/20 0.85
ALDH1A1 P00352 1/20 0.85
PLA2G1B P04054 1/20 0.85
TP53 P04637 1/20 0.85
PGR P06401 1/20 0.85
HSP90AA1 P07900 1/20 0.85
CYP3A4 P08684 1/20 0.85
MAPT P10636 1/20 0.85
IDO1 P14902 1/20 0.85
HPGD P15428 1/20 0.85
MAOA P21397 1/20 0.85
CNR1 P21554 1/20 0.85
HTR2A P28223 1/20 0.85
MAPK1 P28482 1/20 0.85
ADRA1A P35348 1/20 0.85
OPRK1 P41145 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bifonazole SCHEMBL1606037 0.92 CYP17A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
Bifonazole SCHEMBL1551534 0.92 CYP17A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
Bifonazole SCHEMBL36803 0.92 CYP17A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
Bifonazole SCHEMBL394764 0.92 CYP17A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
Bifonazole SCHEMBL7598897 0.92 CYP17A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
SCHEMBL11349905 0.90 CYP17A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
SCHEMBL2491523 0.88 CYP19A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11
SCHEMBL11355060 0.87 CYP17A1 (0.78) CYP17A1MEN1NR1I2USP2ABCB11
SCHEMBL11354911 0.87 CYP17A1 (0.78) CYP17A1MEN1NR1I2USP2ABCB11
SCHEMBL738495 0.87 CYP19A1 (1.00) CYP17A1MEN1NR1I2USP2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227425-A1 REAGENTS AND PROCESS FOR DIRECT C-H FUNCTIONALIZATION STUDIENGESELLSCHAFT KOHLE MBH (DE) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227425-A1 REAGENTS AND PROCESS FOR DIRECT C-H FUNCTIONALIZATION CFH, DOHH, CTSH CYP17A1 2259/4885MEN1 2782/4885NR1I2 4666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.